Delivery Order SPE2DR25D2104-SPE2DR26F3PCU
- Not listed
- The Defense Logistics Agency awarded a $2,266.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Protonix 40 mg suspension. This non-competitive delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,773.18 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Protonix 40 mg suspension (30-count units) on June 18, 2025, with a ceiling value of $1,461.88 and completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pharmaceutical supply to support federal medical procurement needs. The award was issued without set-aside designation, reflecting AmerisourceBergen's established capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $5,591.48 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROTONIX 40 MG SUSPENSION 30S, a pharmaceutical product, with a ceiling value of $8,111.03 and a completion date of July 16, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,972.12 delivery order is for Protonix 40 mg suspension, a pharmaceutical product used by the Department of Defense. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA,...
- This federal contract award is for the delivery of PROTONIX 40 MG SUSPENSION 30S to the Defense Logistics Agency, a defense agency. The $6,674.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of PROTONIX 40 MG SUSPENSION 30S, a prescription medication. The contract has a ceiling value of $2,742.80 and a completion date of July 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous other federal contracts by the DLA and other...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,851.37 firm fixed-price contract is for the delivery of Protonix IV 40 mg vials, a medication used to treat gastroesophageal reflux disease (GERD) and other conditions. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm-fixed price delivery order contract by the Defense Logistics Agency (DLA) for the provision of PROTONIX 40 MG SUSPENSION 30S pharmaceuticals. The contract has a potential value of $1,816.45 and a completion date of March 1, 2024. This delivery order is placed under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of up to $999,999,999.00...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PCUDelivery Order
This delivery order, valued at $6,319.00, was awarded to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Protonix 40 mg suspension (30-count units). The contract is funded by the Defense Logistics Agency under the Department of Defense and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is November 17, 2025. This award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp functions as a critical vendor within the federal medical procurement system, fulfilling pharmaceutical and medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 11/14/25 |